Dr. Josep Bassaganya-Riera is the Director of the Nutritional Immunology and Molecular Medicine Laboratory (NIMML). He has held and currently holds many research grants from various sources including the National Institutes of Health, the United States Department of Agriculture, and industrial corporations. He is the Principal Investigator and Director for the Modeling Immunity to Enteric Pathogens (MIEP) project, a $10.6 million Center that investigates the immunoregulatory mechanisms underlying infections with gut pathogens by applying mathematical systems to mucosal immunology. He is also Principal Investigator on an RO1 award designed to study the mechanisms of immune modulation by abscisic acid. Dr. Bassaganya-Riera has published over 90 scientific papers, 7 patents and manages an active research portfolio of $12M. Dr. Bassaganya-Riera is the Founder of BioTherapeutics, a pre-clinical stage biotech Company with the mission to develop novel personalized medicine interventions for human diseases.